| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, and Department of Chemical Biology and Pharmacognosy, College of Pharmacy, Rutgers University, Piscataway, New Jersey 08855-0789
Metabolic activation may be a key step in determining the tissue specificity of carcinogenic nitrosamines. In previous work, we characterized P450IIE1 (an acetone/ethanol-inducible form of cytochrome P-450) as the major enzyme for the metabolic activation of N-nitrosodimethylamine. In this work, we investigated the metabolism of other N-nitrosodialkylamines in rat liver microsomes and in reconstituted monooxygenase systems containing purified cytochrome P-450 isozymes. The enzyme specificities in the metabolism of N-nitrosoethylmethylamine and N-nitrosodiethylamine were similar to those of N-nitrosodimethylamine; i.e., these substrates were more efficiently metabolized by acetone- or ethanol-induced microsomes than by other types of microsomes. However, substituting one methyl group with a benzyl or butyl group, as in N-nitrosobenzylmethylamine or N-nitrosobutylmethylamine (NBMA), substantially changed the enzyme specificity. P450IIE1 efficiently catalyzed the demethylation but not the debutylation of NBMA, whereas P450IIB1 (a phenobarbital-inducible form) efficiently catalyzed both the debutylation and demethylation reactions. In the demethylation of NBMA by P450IIE1, the addition of cytochrome b5 markedly increased the activity at low but not at high substrate concentrations, suggesting a decrease in Km value. This effect, however, was not observed in the debutylation of NBMA by P450IIE1 or P450IIB1, and in the demethylation of NBMA by P450IIB1. These studies demonstrate the substrate specificity and alkyl group selectivity in the metabolism of nitrosamines by cytochrome P-450 isozymes.
1 Supported by NIH Grants CA 37037 and ES 03938.
2 To whom requests for reprints should be addressed, at Rutgers University. All authors are currently at this address.
Received 4/ 8/88. Revised 7/25/88. Revised 10/21/88. Accepted 11/30/88.
This article has been cited by other articles:
![]() |
L. F. Ribeiro Pinto, E. Moraes, R. M. Albano, M. C. Silva, W. Godoy, T. Glisovic, and M. A. Lang Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis Carcinogenesis, November 1, 2001; 22(11): 1877 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Brookman-Amissah, A. G. Mackay, and P. F. Swann Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus Carcinogenesis, January 1, 2001; 22(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gopalakrishnan, M. A. Morse, J. Lu, C. M. Weghorst, C. L.K. Sabourin, G. D. Stoner, and S. E. Murphy Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine Carcinogenesis, May 1, 1999; 20(5): 885 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Chen, X. Wang, G. Xu, L. Zhou, J. L. Vennerstrom, F. Gonzalez, H. V. Gelboin, and S. S. Mirvish Depentylation of [3H-pentyl]Methyl-n-amylnitrosamine by Rat Esophageal and Liver Microsomes and by Rat and Human Cytochrome P450 Isoforms Cancer Res., January 1, 1999; 59(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |